Avecho Biotechnology Limited (ASX:AVE)

Avecho Biotechnology Revenue

In the year 2025, Avecho Biotechnology had annual revenue of 1.24M AUD with 9.28% growth. Avecho Biotechnology had revenue of 677.69K in the half year ending December 31, 2025, with 2,399.61% growth.

• Revenue: 1.24M
• Revenue Growth: +9.28%
• P/S Ratio: 37.14
• Revenue / Employee: 82.52K
• Employees: 15
• Market Cap: 45.97M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.24M	105.09K	9.28%
Dec 31, 2024	1.13M	659.12K	139.19%
Dec 31, 2023	473.55K	-655.71K	-58.07%
Dec 31, 2022	1.13M	335.66K	42.30%
Dec 31, 2021	793.60K	408.97K	106.33%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 28, 2026

Data Sources Report a data error